Efficacy of Rostafuroxin in the Treatment of Essential Hypertension

Clinical trial NCT00415038 · COMPLETED

Trial details

NCT number: NCT00415038
Sponsor: sigma-tau i.f.r. S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2005-02-01
Primary completion: 2007-04-01
Enrollment: 438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.